Drug development group NDA Group has opened a new operation in Switzerland called NDA Regulatory Service Switzerland, appointing Dr. Stephanie Krumholz-Bahner as General Manager.
Located in Zürich, the new operation will support specific Swiss development requirements, as well as supporting NDA’s clients local to the area with their global drug development needs.
“NDA Group has ambitious global expansion plans”, said Johan Strömquist, CEO, NDA Group. “The step to start an operation in Switzerland follows last year’s establishment of an office in Boston, USA, to complement our existing presence in the UK, Germany and Sweden. Our clients are operating on a global scale. We are now rapidly moving beyond regional boundaries and need to be present in the key markets to support the growing needs of the industry”, continued Mr. Strömquist. “Opening an office in Switzerland means we can be even closer to our Swiss client base to further improve the quality and frequency of our interactions, as well as better support our global clientele in reaching the Swiss market more efficiently.”